Literature DB >> 21599001

Novel flavonoids with antiproliferative activities against breast cancer cells.

Nianhuan Yao1, Chao-Yu Chen, Chun-Yi Wu, Kiyomi Motonishi, Hsing-Jien Kung, Kit S Lam.   

Abstract

A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC(50) of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC(50) = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21599001      PMCID: PMC3169196          DOI: 10.1021/jm101440r

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  30 in total

1.  Semirational design of a potent, artificial agonist of fibroblast growth factor receptors.

Authors:  M D Ballinger; V Shyamala; L D Forrest; M Deuter-Reinhard; L V Doyle; J X Wang; L Panganiban-Lustan; J R Stratton; G Apell; J A Winter; M V Doyle; S Rosenberg; W M Kavanaugh
Journal:  Nat Biotechnol       Date:  1999-12       Impact factor: 54.908

2.  Catecholic flavonoids acting as telomerase inhibitors.

Authors:  Maria Menichincheri; Dario Ballinari; Alberto Bargiotti; Luisella Bonomini; Walter Ceccarelli; Roberto D'Alessio; Antonella Fretta; Juergen Moll; Paolo Polucci; Chiara Soncini; Marcellino Tibolla; Jean-Yves Trosset; Ermes Vanotti
Journal:  J Med Chem       Date:  2004-12-16       Impact factor: 7.446

3.  Why drinking green tea could prevent cancer.

Authors:  J Jankun; S H Selman; R Swiercz; E Skrzypczak-Jankun
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

4.  Mapping signal transduction pathways by phage display.

Authors:  S Zozulya; M Lioubin; R J Hill; C Abram; M L Gishizky
Journal:  Nat Biotechnol       Date:  1999-12       Impact factor: 54.908

Review 5.  Flavonoids: old and new aspects of a class of natural therapeutic drugs.

Authors:  G Di Carlo; N Mascolo; A A Izzo; F Capasso
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

6.  eEF1A2 activates Akt and stimulates Akt-dependent actin remodeling, invasion and migration.

Authors:  A Amiri; F Noei; S Jeganathan; G Kulkarni; D E Pinke; J M Lee
Journal:  Oncogene       Date:  2006-11-20       Impact factor: 9.867

Review 7.  Estrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer.

Authors:  Christa K Baumann; Monica Castiglione-Gertsch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Synthesis and biological evaluation of novel flavone-8-acetic acid derivatives as reversible inhibitors of aminopeptidase N/CD13.

Authors:  Brigitte Bauvois; Marie-Line Puiffe; Jean-Bernard Bongui; Sandrine Paillat; Claude Monneret; Daniel Dauzonne
Journal:  J Med Chem       Date:  2003-08-28       Impact factor: 7.446

9.  Protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer.

Authors:  Nisha Anand; Sabita Murthy; Gudrun Amann; Meredith Wernick; Lisa A Porter; I Howard Cukier; Colin Collins; Joe W Gray; Joachim Diebold; Doug J Demetrick; Jonathan M Lee
Journal:  Nat Genet       Date:  2002-06-10       Impact factor: 38.330

Review 10.  The role of protein elongation factor eEF1A2 in ovarian cancer.

Authors:  Jonathan M Lee
Journal:  Reprod Biol Endocrinol       Date:  2003-10-07       Impact factor: 5.211

View more
  7 in total

1.  Synthesis and anti-breast cancer activity of novel indibulin related diarylpyrrole derivatives.

Authors:  Ebrahim Saeedian Moghadam; Ernest Hamel; Zahra Shahsavari; Mohsen Amini
Journal:  Daru       Date:  2019-03-20       Impact factor: 3.117

2.  Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.

Authors:  Kevin Bonfield; Erica Amato; Tony Bankemper; Hannah Agard; Jeffrey Steller; James M Keeler; David Roy; Adam McCallum; Stefan Paula; Lili Ma
Journal:  Bioorg Med Chem       Date:  2012-02-27       Impact factor: 3.641

3.  Eukaryotic elongation factor 1 complex subunits are critical HIV-1 reverse transcription cofactors.

Authors:  Kylie Warren; Ting Wei; Dongsheng Li; Fangyun Qin; David Warrilow; Min-Hsuan Lin; Haran Sivakumaran; Ann Apolloni; Catherine M Abbott; Alun Jones; Jenny L Anderson; David Harrich
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-24       Impact factor: 11.205

4.  Novel harmine derivatives for tumor targeted therapy.

Authors:  Siwen Li; Aqin Wang; Fan Gu; Zhaohui Wang; Caiping Tian; Zhiyu Qian; Liping Tang; Yueqing Gu
Journal:  Oncotarget       Date:  2015-04-20

Review 5.  The eEF1A Proteins: At the Crossroads of Oncogenesis, Apoptosis, and Viral Infections.

Authors:  Wasim Abbas; Amit Kumar; Georges Herbein
Journal:  Front Oncol       Date:  2015-04-07       Impact factor: 6.244

6.  Novel Structurally Related Flavones Augment Cell Death Induced by rhsTRAIL.

Authors:  Joanna Bronikowska; Ewelina Szliszka; Edyta Kostrzewa-Susłow; Dagmara Jaworska; Zenon P Czuba; Piotr Bednarski; Wojciech Król
Journal:  Int J Mol Sci       Date:  2017-06-06       Impact factor: 5.923

7.  Translation Elongation Factor eEF1A2 is a Novel Anticancer Target for the Marine Natural Product Plitidepsin.

Authors:  Alejandro Losada; María José Muñoz-Alonso; Carolina García; Pedro A Sánchez-Murcia; Juan Fernando Martínez-Leal; Juan Manuel Domínguez; M Pilar Lillo; Federico Gago; Carlos M Galmarini
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.